Pharming Group NV
Biotechnology
Healthcare
PHAR
77.63 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
14.92
52 week high
15.26
high
15.07
52 week low
0.00
previous Close
14.83
P/E ratio
market cap
855 M
div yield
0
net incoming
4.66 M
131.65 %
net profit margin
4.94 %
23.00 %
operating incoming
11.24 M
259.57 %
net change in cash
34.72 M
574.38 %
cash on hand
94.82 M
57.78 %
cost of revenue
9.11 M
9.50 %
top